Physician profile
Daniel A Tramuta
NPI 1902803612
$11,024.66
in general payments reported to CMS, 2019-2025
42 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,134 · 2020: $1,153 · 2021: $1,136 · 2022: $2,165 · 2023: $1,580 · 2024: $692 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,436.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,331.30 | 2019-2024 | Wolverine Coronary Cutting Balloon, Avvigo Guidance System, Watchman Access System |
| Medtronic Vascular, INC. | $1,021.39 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $1,017.85 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $983.72 | 2019-2023 | Xarelto |
| Amgen INC. | $972.79 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $798.02 | 2019-2022 | |
| Abiomed | $761.07 | 2019-2024 | Impella |
| Medtronic, INC. | $540.96 | 2021-2024 | Onyx Frontier, Ffrangio |
| E.R. Squibb & Sons, L.L.C. | $435.32 | 2019-2024 | Camzyos |
| Bardy Diagnostics, INC. | $261.97 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $258.79 | 2019-2023 | Lifevest |
| Edwards Lifesciences Corporation | $254.43 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Sanofi-Aventis U.S. LLC | $245.44 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $220.94 | 2020-2024 | Jardiance |
| Irhythm Technologies, INC. | $195.88 | 2019-2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $176.09 | 2019-2024 | |
| Amarin Pharma, INC. | $152.19 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $145.47 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $141.61 | 2021-2022 | |
| Lantheus Medical Imaging, INC. | $136.35 | 2019-2020 | |
| Penumbra, INC. | $132.64 | 2023 | Indigo System |
| Inari Medical, INC. | $118.92 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Regeneron Healthcare Solutions, INC. | $84.63 | 2019 | |
| Pfizer INC. | $80.05 | 2019-2023 | |
| Cardiovascular Systems INC. | $63.57 | 2019-2021 | |
| Reflow Medical INC | $63.45 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.16 | 2021-2022 | |
| Baxter Healthcare | $49.30 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Chiesi USA, INC. | $44.13 | 2019-2020 | |
| Ekos Corporation | $36.57 | 2019 | |
| Livanova USA, INC. | $34.52 | 2020 | |
| Astellas Pharma US INC | $31.80 | 2019-2020 | |
| Cook Medical LLC | $27.03 | 2019 | |
| Medtronic USA, INC. | $25.40 | 2019 | |
| Vital Connect, INC | $18.79 | 2024 | Vitalpatch Rtm |
| Atricure, INC. | $18.33 | 2023 | |
| Lundbeck LLC | $17.80 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $16.83 | 2020 | |
| Philips North America LLC | $16.74 | 2024 | (Ck7) Extended Holter |
| Daiichi Sankyo INC. | $15.56 | 2019 | |
| Gilead Sciences, INC. | $12.65 | 2019 | |
| Esperion Therapeutics, INC. | $11.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Tramuta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.